Although Naltrexone is a drug, the site is not about drug treatment for
MS. It is about how this
unique effect of blocking opioid receptors for 4-6 hours a day results
in a rebound modulation of the immune system. There may also be effects
on oxidative stress through Nitric Oxide and also DNA replication. The
drug is a shift in paradigm. It increases Met-5-enkephaline which is
natural and can be used, aka Opioid Growth Factor is costs $3,000 a
month and does not have the full range of benefits.
It has saved many with MS from the terrible side effects and costs of
the CRAB drugs.
Their MS stops progressing in 90% of the cases. There are now studies
and many case
histories, some who have been taking LDN for over five years.
It is a super low dose and has a huge margin of safety. Some MS patients
take as little as 2 mg, others are using 0.5 mg once a week for immune
balancing. FM is relieved, Crohns,
Austism, AIDS . . . any immune system disorder may respond.
The drug is out of patent so there is no profit motive to push this
treatment. It is all patient driven.
Natural is good, but if you broke your arm would you allow it to heal
naturally?
I'm not saying not to use natural means, many who take LDN do, and the
doctors generally are holistic with an emphasis on diet and nutriceuticals.
Where there is sensible safe treatment it never hurts to investigate.
Janet
carolG wrote:
Is site drug oriented for MS? There is great information for the non
drug users and those wanting to go more natural. Just wanted people to
be exposed to both choices and it's really their choice once they have
knowledge as it is power.
Thanks for sharing.
carol
------------------------------------------------------------------------
*From:* Garnet_LDN <[email protected]>
*To:* [email protected]
*Sent:* Tue, July 20, 2010 5:53:09 PM
*Subject:* Re: CS>Multiple Sclerosis
http://www.free-press-release.com/news-new-website-aims-to-clear-up-misconceptions-about-breakthrough-drug-low-dose-naltrexone-ldn-1268301980.html
“Having instigated the first clinical trial for LDN in 2004 at Penn
State University, I am gratified that we’ve now launched this
informative resource for physicians and patients,� Rogosnitzky added.
“We aim to summarize almost 30 years of research, carried out by the
discoverers of LDN, Dr. Ian S. Zagon and Dr. Patricia J. McLaughlin at
Penn State University, and provide an invaluable resource which will
enable this therapy to be used properly, inspire further research into
its many possible uses and eventually lead to its acceptance as
mainstream therapy for a number of incurable conditions.�
--
The Silver List is a moderated forum for discussing Colloidal Silver.
Rules and Instructions: http://www.silverlist.org
Unsubscribe:
<mailto:[email protected]?subject=unsubscribe>
Archives:
http://www.mail-archive.com/[email protected]/maillist.html
Off-Topic discussions: <mailto:[email protected]>
List Owner: Mike Devour <mailto:[email protected]>
